TABLE 3.
Metabolites | ESI+/− | Super class | VIP | FC | p-value | Q-value | Trend |
---|---|---|---|---|---|---|---|
Allantoin | − | Organoheterocyclic compounds | 2.87 | 4.47 | 0.003 | 0.018 | Up |
Theophylline | − | Organoheterocyclic compounds | 2.18 | 4.39 | 0.001 | 0.010 | Up |
Cytidine | − | Nucleosides, nucleotides, and analogues | 2.77 | 3.29 | 0.005 | 0.028 | Up |
Succinic acid semialdehyde | − | Lipids and lipid-like molecules | 1.15 | 3.13 | 0.006 | 0.031 | Up |
D-2,3-Dihydroxypropanoic acid | − | Organic oxygen compounds | 2.41 | 2.02 | 0.001 | 0.012 | Up |
Allopurinol | − | Organoheterocyclic compounds | 1.97 | 0.41 | <0.001 | 0.002 | Down |
Gamma-linolenic acid | − | Lipids and lipid-like molecules | 1.93 | 0.20 | <0.001 | 0.002 | Down |
Sedoheptulose | − | Organic oxygen compounds | 2.50 | 0.20 | <0.001 | <0.001 | Down |
Inosine | − | Nucleosides, nucleotides, and analogs | 2.69 | 0.13 | <0.001 | <0.001 | Down |
Tolmetin | + | Organic oxygen compounds | 1.88 | 6.10 | 0.006 | 0.016 | Up |
Oleamide | + | Lipids and lipid-like molecules | 2.16 | 5.33 | 0.004 | 0.013 | Up |
Glycerophosphocholine | + | Lipids and lipid-like molecules | 2.62 | 4.12 | 0.002 | 0.009 | Up |
Trigonelline | + | Alkaloids and derivatives | 1.44 | 4.05 | 0.024 | 0.038 | Up |
Decanoylcarnitine | + | Lipids and lipid-like molecules | 1.45 | 2.67 | 0.026 | 0.040 | Up |
L-Cycl o(alanylglycyl) | + | Organoheterocyclic compounds | 1.32 | 2.62 | 0.004 | 0.013 | Up |
L-alpha-Aspartyl-l-hydroxyproline | + | Organic acids and derivatives | 1.35 | 2.58 | 0.021 | 0.036 | Up |
4,8 Dimethylnonanoyl carnitine | + | Lipids and lipid-like molecules | 1.18 | 2.42 | 0.011 | 0.023 | Up |
Choline | + | Organic nitrogen compounds | 2.68 | 2.31 | <0.001 | 0.001 | Up |
1-Pyrrolidinecarboxaldehyde | + | Organoheterocyclic compounds | 1.25 | 2.24 | 0.035 | 0.048 | Up |
2-Methylbutyroylcarnitine | + | Lipids and lipid-like molecules | 2.09 | 2.17 | <0.001 | 0.003 | Up |
PC(P-18:1 (11Z)/20:5 (5Z,8Z,11Z,14Z,17Z)) | + | Lipids and lipid-like molecules | 1.09 | 2.16 | 0.011 | 0.024 | Up |
Montecristin | + | Lipids and lipid-like molecules | 2.45 | 2.07 | <0.001 | 0.002 | Up |
l-Phenylalanine | + | Organic acids and derivatives | 2.61 | 2.06 | <0.001 | <0.001 | Up |
Hypoxanthine | + | Organoheterocyclic compounds | 1.76 | 0.47 | 0.002 | 0.008 | Down |
Isoleucyl-alanine | + | Organic acids and derivatives | 1.35 | 0.37 | <0.001 | 0.003 | Down |
Desglucocheirotoxin | + | Lipids and lipid-like molecules | 2.29 | 0.23 | <0.001 | <0.001 | Down |
Isoleucyl-valine | + | Organic acids and derivatives | 2.38 | 0.17 | <0.001 | <0.001 | Down |
Arabinosylhypoxanthine | + | Nucleosides, nucleotides, and analogs | 2.17 | 0.13 | <0.001 | <0.001 | Down |
2-(3,4-Dihydroxybenzoyloxy)-4,6-dihydroxybenzoate | + | Phenylpropanoids and polyketides | 2.34 | 0.11 | <0.001 | <0.001 | Down |
Sertindole | + | Organoheterocyclic compounds | 1.27 | 0.02 | <0.001 | 0.003 | Down |
8beta-Angeloyloxy-15-hydroxy-1alpha,10R-dimethoxy-3-oxo-11(13)-germacren-12,6alpha-olide | + | Lipids and lipid-like molecules | 1.35 | 0.02 | <0.001 | 0.002 | Down |
Note: ESI, electrospray ionization; VIP, variable importance in the projection; FC, fold change.